Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Hicks

Showing results (191-200 of 471) with videos related to

Pageof 48
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 23, 2017
<sup>68</sup>Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancerAmir Iravani, Michael S Hofman, Tony Mulcahy, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Journal of Critical Care|September 15, 2020
Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case reportJayesh Dhanani, David A Pattison, Matthew Burge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTAMichael Hofman, David Binns, Val Johnston, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2018
Outcome of patients with early-stage follicular lymphoma staged with <sup>18</sup>F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy aloneSweet Ping Ng, Richard Khor, Mathias Bressel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
Haematologica|May 3, 2008
A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapyMark J Bishton, Rodney J Hicks, David A Westerman, et al.
Scientific Reports|June 25, 2020
Enhancing the anti-tumour activity of <sup>177</sup>Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARPCarleen Cullinane, Kelly Waldeck, Laura Kirby, et al.
Gene|December 3, 2014
Regulation of rDNA transcription in response to growth factors, nutrients and energyEric P Kusnadi, Katherine M Hannan, Rodney J Hicks, et al.
Cancer|March 3, 2011
Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancerShankar Siva, Alan Herschtal, Jessica M Thomas, et al.
Pageof 48

Showing results (191-200 of 471) with videos related to

Sort By:
Pageof 48
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 23, 2017
<sup>68</sup>Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancerAmir Iravani, Michael S Hofman, Tony Mulcahy, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Journal of Critical Care|September 15, 2020
Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case reportJayesh Dhanani, David A Pattison, Matthew Burge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTAMichael Hofman, David Binns, Val Johnston, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2018
Outcome of patients with early-stage follicular lymphoma staged with <sup>18</sup>F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy aloneSweet Ping Ng, Richard Khor, Mathias Bressel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
Haematologica|May 3, 2008
A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapyMark J Bishton, Rodney J Hicks, David A Westerman, et al.
Scientific Reports|June 25, 2020
Enhancing the anti-tumour activity of <sup>177</sup>Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARPCarleen Cullinane, Kelly Waldeck, Laura Kirby, et al.
Gene|December 3, 2014
Regulation of rDNA transcription in response to growth factors, nutrients and energyEric P Kusnadi, Katherine M Hannan, Rodney J Hicks, et al.
Cancer|March 3, 2011
Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancerShankar Siva, Alan Herschtal, Jessica M Thomas, et al.
Pageof 48